Sanofi

SNY · NASDAQ · USD

$39.92−1.84%−$0.75

Close · October 2, 2026

At a glance

Revenue growth: +5.49%; 2025 vs 2024
Net income growth: +40.52%; 2025 vs 2024
Net margin: 16.7%; 2024: 12.6%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total assets	129,060	128,024	126,805	129,794	124,959	131,892	132,798	—	129,755	—	126,464	—
Current assets	31,522	30,164	30,952	34,042	37,017	44,019	42,588	—	30,081	—	30,670	—
Cash and equivalents	6,350	5,544	7,657	8,906	15,359	7,991	7,441	—	6,795	—	8,710	—
Short-term investments	—	—	810	—	—	—	—	—	—	—	—	—
Receivables	9,206	482	11,046	497	8,207	447	10,629	—	8,805	—	11,040	—
Inventory	11,127	23,503	10,214	24,501	9,618	21,850	9,431	—	10,609	—	9,666	—
Net property, plant and equipment	11,954	11,674	11,511	11,181	11,007	11,352	11,601	—	11,880	—	11,814	—
Goodwill	41,954	—	41,300	—	40,283	—	43,384	—	50,080	—	49,404	—
Other intangible assets	18,333	69,086	17,530	68,867	12,383	63,809	14,260	—	18,123	—	18,281	—
Long-term investments	7,104	—	6,854	—	6,995	—	3,259	—	2,640	—	2,666	—
Current liabilities	31,930	30,008	28,345	32,105	29,059	32,221	29,162	—	30,027	—	24,207	—
Accounts payable	7,150	22,708	7,361	22,000	7,075	21,616	7,551	—	7,433	—	7,328	—
Long-term debt	14,646	12,298	14,329	11,700	13,200	11,767	11,791	—	12,503	—	14,347	—
Total debt	23,441	14,100	20,170	13,553	22,146	13,676	17,713	—	16,581	—	—	—
Total liabilities	59,493	54,881	55,095	56,261	54,680	57,474	54,941	—	56,758	—	52,111	—
Total equity (incl. minority)	69,567	73,143	71,710	73,533	70,279	74,418	77,857	72,997	72,997	74,353	74,353	72,947
Minority interest	360	335	334	270	271	344	350	—	307	—	313	—